LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 40.95
-0.55 (-1.33%)
Mar 5, 2026, 1:35 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 3.3 billion as of March 5, 2026. Its market cap has increased by 78.04% in one year.
Market Cap
3.30B
Enterprise Value
2.86B
Revenue
125.54M
Ranking
n/a
PE Ratio
21.11
Stock Price
40.95
Market Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 3.30B, an increase of 91.65%. That is a compound annual growth rate of 2.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 3.35B | 27.89% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient EuroPharma | 3.81B |
| Easywell Biomedicals | 3.68B |
| Merdury Biopharmaceutical | 3.56B |
| Maywufa Company | 2.94B |
| PhytoHealth | 2.73B |
| Allied Biotech | 2.56B |
| Johnson Chemical Pharmaceutical Works | 2.55B |
| Golden Biotechnology | 2.30B |